Hogy Medical Co.,Ltd.
Hogy Medical Co.,Ltd. (HGYMF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
hgymf · pe ratio · data through Mar 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Hogy Medical Co.,Ltd. (HGYMF) measures how much investors pay for each dollar of the company's trailing earnings. HGYMF's current PE ratio of 646.79x is calculated by dividing its stock price of $43.47 by its TTM earnings per share of $10.30. +1935.9% elevated vs 5Y avg 31.8x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-03-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 20 fiscal years · Front-end computedMinQ1 · 25%33.7x
MedianQ3 · 75%5167.5x
Max
At 646.79x, HGYMF's current P/E is higher than in 75% of its annual fiscal year readings over the past 20 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Hogy Medical Co.,Ltd.You HGYMF | $937M | 646.79x | +2283.0% | $10.30 |
 AB Science S.A. ABSCF | $78M | N/A | — | -$0.03 |
 EL.En. S.p.A. ELEAF | $760M | 19.67x | -27.5% | $0.54 |
 Valneva SE INRLF | $531M | N/A | — | -$0.68 |
 JINS HOLDINGS Inc. JNDOF | $1.1B | 9.37x | -65.5% | $356.88 |
 Veradigm Inc. MDRX | $777M | N/A | — | -$0.67 |
 Nanosonics Limited NNCSF | $619M | 52.39x | +93.0% | $0.07 |
Industry Average 3 peers with valid PE | — | 27.14x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-03-31Latest FY2025 | 53.71x | $67.95 | +66.4% | |
2024-03-31 FY2024 | 32.29x | $115.54 | +31.7% | |
2023-03-31 FY2023 | 24.52x | $177.93 | -6.2% | |
2022-03-31 FY2022 | 26.14x | $152.99 | +17.9% | |
2021-03-31 FY2021 | 22.18x | $164.03 | -98.9% | |
2020-03-31 FY2020 | 2083.81x | $1.70 | +15.4% | |
2019-03-31 FY2019 | 1805.29x | $1.79 | -65.1% | |
2018-03-31 FY2018 | 5167.53x | $1.58 | +26.5% | |
2017-03-31 FY2017 | 4085.32x | $1.66 | +25.5% | |
2016-03-31 FY2016 | 3255.64x | $1.67 | +10168.8% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Hogy Medical Co.,Ltd. (HGYMF) measures how much investors pay for each dollar of the company's trailing earnings. HGYMF's current PE ratio of 646.79x is calculated by dividing its stock price of $43.47 by its TTM earnings per share of $10.30.
Frequently asked questions
HGYMF pe ratio · 6 questionsHGYMF's current PE ratio is 646.79x as of 2026-06-09, based on a stock price of $43.47 and TTM EPS of $10.30. Data sourced from Financial Modeling Prep via HGYMF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Hogy Medical Co.,Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09